Questor is The Telegraph’s stockpicking column, helping you decode the markets and offering insights on where to invest for ...

The 2024 increase is the same as last year.The foundation’s annual survey of employer health benefits also found that only 18 ...

Good evening. As Hurricane Milton barrels toward the west coast of Florida ahead of an expected landfall tonight, the ...

LONDON and NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicine company, today announced a poster presentation at ...

Some of the most valuable health advancements in 2024 related to weight loss and metabolic health. New findings about ...

A large study of veterans with type 2 diabetes finds better short-term kidney outcomes with use of SGLT2 inhibitors vs GLP-1 receptor agonists.

American adults prefer dietary change as a weight loss method, over injectable weight loss drugs such as Ozempic, a survey says.

While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...

Adults with type 2 diabetes using metformin had a slightly lower risk of dying or developing long COVID within 180 days after ...

Skye Bioscience (NASDAQ: SKYE) is a micro-cap pharmaceutical company that is striving to become the next big thing in the ...

Doctors have issued a serious health warning over the extremely dangerous ‘faux-zempic’ as the weight loss drugs see an ...